1Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada.
2Shiraz HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
3Department of Nutrition, Shiraz University of Medical Sciences School of Nutrition and Food Sciences, Shiraz, Iran.
4Department of Physical Therapy, Shiraz University of Medical Sciences School of Rehabilitation Sciences, Shiraz, Iran.
5Department of Epidemiology, Student Research Committee, Shiraz University of Medical Sciences School of Health, Shiraz, Iran.
Copyright © 2017 Korean Diabetes Association
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Antidiabetic Effects of Physical Activity: How It Helps to Control Type 2 Diabetes
Characteristic | Control (n=15) | Resistance (n=15) | Aerobic (n=15) | Combination (n=15) | P valuea |
---|---|---|---|---|---|
Height, cm | 153.18±5.86 | 157.65±3.43 | 155.75±6.57 | 155.18±5.32 | 0.64 |
Weight, kg | 68.65±7.45 | 72.44±6.37 | 72.64±12.89 | 69.79±6.11 | 0.82 |
BMI, kg/cm2 | 28.15±3.72 | 29.11±1.92 | 30.03±5.48 | 29.01±2.57 | 0.85 |
Body fat, % | 35.35±5.12 | 36.41±3.05 | 37.03±4.22 | 36.29±3.98 | 0.74 |
Muscle, kg | 40.17±4.56 | 41.75±3.95 | 41.74±5.16 | 40.18±3.86 | 0.92 |
Glucose, mg/dL | 181.87±12.20 | 169.80±22.64 | 172.20±18.14 | 170.00±21.25 | 0.50 |
Insulin, µIU/mL | 12.70±3.39 | 14.43±3.09 | 13.25±3.92 | 12.16±3.62 | 0.47 |
HOMA-IR | 5.66±1.37 | 5.94±0.98 | 5.50±1.2 | 4.97±0.98 | 0.26 |
Omentin, ng/mL | 24.17±5.75 | 29.00±4.90 | 27.67±7.60 | 31.90±4.12 | 0.74 |
Variable | Control (n=15) | Resistance (n=12) | Aerobic (n=12) | Combination (n=13) | P valueb | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pre- | Post- | % ∆ | P valuea | Pre- | Post- | % ∆ | P valuea | Pre- | Post- | % ∆ | P valuea | Pre- | Post- | % ∆ | P valuea | ||
Weight, kg | 68.65±7.45 | 67.82±7.80 | 1.22 | 0.18 | 72.44±6.37 | 70.92±7.03 | 1.74 | 0.02 | 72.64±12.89 | 71.94±13.19 | 1.08 | 0.33 | 69.79±6.11 | 68.30±6.75 | 2.19 | 0.01 | 0.732 |
BMI, kg/cm2 | 28.15±3.72 | 28.17±3.52 | 0.21 | 0.36 | 29.11±1.92 | 28.54±1.98 | 1.70 | 0.02 | 30.03±5.48 | 29.73±5.57 | 1.08 | 0.32 | 29.01±2.57 | 28.37±2.57 | 2.19 | 0.01 | 0.387 |
Body fat, % | 35.35±5.12 | 35.07±5.19 | 5.18 | 0.27 | 36.41±3.05 | 35.88±3.15 | 11.04 | 0.13 | 37.03±4.22 | 35.39±4.32 | 10.26 | 0.01 | 36.29±3.98 | 34.31±4.07c,d | 11.97 | 0.001 | 0.023 |
Muscle, kg | 40.17±4.56 | 41.30±4.56 | 2.96 | 0.07 | 41.75±3.95 | 43.47±5.17 | 3.35 | 0.02 | 41.74±5.16 | 43.24±5.25 | 4.22 | 0.05 | 40.18±3.86 | 41.72±4.06 | 3.83 | 0.001 | 0.84 |
Glucose, mg/dL | 181.87±12.20 | 166.62±8.27 | 7.99 | 0.02 | 169.80±22.64 | 129.20±23.85c | 22.21 | 0.005 | 172.20±18.14 | 139.70±21.71c | 24.58 | 0.001 | 40.18±3.86 | 123.45±9.34c | 26.43 | 0.001 | 0.001 |
Insulin, μIU/mL | 12.70±3.39 | 14.30±3.36 | 14.40 | 0.11 | 14.43±3.09 | 18.53±5.65 | 29.33 | 0.02 | 13.25±3.92 | 14.90±5.51 | 13.08 | 0.15 | 12.16±3.62 | 13.01±3.62 | 10.02 | 0.32 | 0.168 |
HOMA-IR | 5.66±1.37 | 5.90±1.56 | 5.01 | 0.56 | 5.94±0.98 | 18.53±5.65 | 4.95 | 0.059 | 5.50±1.2 | 4.53±0.88c,d | 16.50 | 0.004 | 4.97±0.98 | 3.92±1.11c,d | 19.67 | 0.005 | 0.002 |
Omentin, | 24.17± | 21.41± | 10.47 | 0.11 | 29.00± | 31.76± | 28.63 | 0.59 | 27.67± | 29.09± | 19.23 | 0.66 | 31.90± | 48.82± | 65.48 | 0.001 | 0.002 |
Variable | Omentin | BMI | Body fat percent | HOMA-IR |
---|---|---|---|---|
Omentin | 1.0 | - | - | - |
BMI | –0.301a | 1.0 | - | - |
Body fat percent | –0.532b | 0.965 | 1.0 | - |
HOMA-IR | –0.801b | 0.677 | –0.178 | 1.0 |
Values are presented as mean±standard deviation. BMI, body mass index; HOMA-IR, homeostasis model assessment of insulin resistance. aAnalysis of variance.
Values are presented as mean±standard deviation. BMI, body mass index; HOMA-IR, homeostasis model assessment of insulin resistance. aPaired sample
BMI, body mass index; HOMA-IR, homeostasis model assessment of insulin resistance. aCorrelation is significant at the 0.05 level (2-tailed), bCorrelation is significant at the 0.01 level (2-tailed).